Minnesota HF1652 prohibits health plans from changing formularies in a way that increases enrollee costs during the plan year.

Minnesota HF1652 aims to protect health plan enrollees by prohibiting health plans from changing formularies in a way that increases enrollee costs during the plan year. Exceptions are made if the drug has been deemed unsafe by the FDA, withdrawn by the FDA or the manufacturer, or if there are drug-specific warnings from independent research. The bill also requires at least 60 days' notice to prescribers, pharmacists, and affected enrollees. This law will take effect on January 1, 2026, and applies to health plans offered, sold, issued, or renewed on or after that date.

Minnesota HF1652 prohibits health plans from changing formularies in a way that increases enrollee costs during the plan year.

Minnesota HF1652 aims to protect health plan enrollees by prohibiting health plans from changing formularies in a way that increases enrollee costs during the plan year. Exceptions are made if the drug has been deemed unsafe by the FDA, withdrawn by the FDA or the manufacturer, or if there are drug-specific warnings from independent research. The bill also requires at least 60 days' notice to prescribers, pharmacists, and affected enrollees. This law will take effect on January 1, 2026, and applies to health plans offered, sold, issued, or renewed on or after that date.